Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Novel coronavirus vaccine antigen presentation system of attenuated salmonella secretory expression NTD structural domain protein and application of novel coronavirus vaccine antigen presentation system

A technology of domain protein and Salmonella, which is applied in the field of construction and preparation of recombinant attenuated Salmonella, can solve the problems of high efficiency, stability, and abnormally difficult secretion of antigen proteins, and achieves a strong price advantage, eliminating the need for adjuvant addition, and simplifying The effect of the operation process

Pending Publication Date: 2022-05-13
NANJING JIRUIKANG BIOTECHNOLOGY RES INST CO LTD +1
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology describes an improved way to deliver virus particles into living organisms through their own natural systems called salmons (Salamia). These viruses are able to enter these organs without causing harmful reactions like other infectious agents such as bacterial endospores. They have been shown to stimulate both humoral responses against specific diseases caused by certain types of influenza A virus. Additionally, they also provide protection from disease when given this virus inside people' s blood vessels during hemorrhage attacks. Overall, this innovative method allows scientists to study how different parts of our world work better while still being safely protected from germs.

Problems solved by technology

The technical problem addressed in this patented patents relating to improving the efficiency and reliability of producing novel anti-influenza drugs has resulted in poor reproducibility between batches during manufacturing processes with varying compositions and concentrations. Additionally, current approaches require expensive materials like virals or enzyme carriers, making them less accessible than liquid ones.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel coronavirus vaccine antigen presentation system of attenuated salmonella secretory expression NTD structural domain protein and application of novel coronavirus vaccine antigen presentation system
  • Novel coronavirus vaccine antigen presentation system of attenuated salmonella secretory expression NTD structural domain protein and application of novel coronavirus vaccine antigen presentation system
  • Novel coronavirus vaccine antigen presentation system of attenuated salmonella secretory expression NTD structural domain protein and application of novel coronavirus vaccine antigen presentation system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Construction of delivery plasmid for antigenic protein novel coronavirus protein NTD

[0042] The NTD protein is a part of the structural region in the new coronavirus S protein ( figure 1 ), considering the large structural region of the S protein, after a large number of multi-angle bioinformatics analyzes and mutual comparisons, it was predicted that the NTD located at positions 13-303 of the overall amino acid sequence of the S protein contains more epitopes site. After a lot of experimental research, try various reported commonly used bacterial secretion systems, secretion signal peptides and matching promoters. In the constitutive expression secretion system Ah-JP-NTD plasmid, after screening, the present invention selects and uses a strong constitutive promoter J23100 and a pelB signal peptide. The gene sequence of the PJ23100-PelB is the nucleotide sequence shown in SEQ ID No.14.

[0043] For the inducible expression of type III secretory expression plasmids,...

Embodiment 2

[0061] Electroporation transformation of recombinant attenuated Salmonella:

[0062]Preparation of electroporation-competent Salmonella: Inoculate fresh attenuated Salmonella into 200mL LB medium, culture on a shaker at 37°C until the OD value is between 0.4-0.6, centrifuge at 5000rpm, collect the bacteria for 5min, and wash once with sterile double distilled water Finally, centrifuge at 5000rpm for 5min, wash the cells with sterilized 10% glycerol for 3-5 times, centrifuge at 5000rpm for 5min, resuspend with 500μL of 10% glycerol, aliquot 50μL / tube for electroporation. Transform the recombinant vaccine DNA vector into attenuated Salmonella by electroporation: under sterile conditions, add 0.5-5 μg of the constructed recombinant vector to the electroporation competent, mix well, and transfer to a 2mm electroporation cup, For electric shock, the electroporation conditions are 1.8kV, 25μF, 500Ω. After electroporation, spread on a kanamycin plate for screening, and the grown col...

Embodiment 3

[0064] Effective secretion detection of antigenic protein

[0065] The obtained recombinant attenuated Salmonella was cultured in kanamycin-resistant liquid LB medium to OD6000.8-1.0, the bacteria were collected and the OD600 value was adjusted to about 1.0 with PBS. Put it at 4 degrees for later use. The macrophage cell line RAW264.7 was induced with 100 ng / mL LPS to obtain M1 macrophages for 24 hours (hereinafter referred to as RAW264.7(M1)). The obtained RAW264.7(M1) was co-cultured with the Ah-BJ-NTD recombinant attenuated Salmonella obtained above at a ratio of 1:10 for 90 minutes, the supernatant was discarded and washed 2-3 times with PBS, and then added with 100ng / mL Qing The cells were cultured in damycin-based cell culture solution (10% serum, without double antibody) for 6 hours. Collect the cells and collect the total cell protein by thermal lysis, that is, resuspend the cells in 100 μL PBS, add 25 μL 5X Loading Buffer, and lyse at 100 degrees for 10-15 minutes. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel coronavirus (SARS-CoV-2) vaccine antigen presentation system of attenuated salmonella secretory expression NTD structural domain protein and application of the novel coronavirus (SARS-CoV-2) vaccine antigen presentation system. The novel coronavirus (SARS-CoV-2) vaccine antigen presentation system is used for preventing novel coronavirus (SARS-CoV-2). By constructing the controllable and stable expression plasmid for secreting and expressing the NTD structural domain protein and performing engineering modification on the attenuated salmonella, the antigenic protein can be efficiently delivered to an antigen presenting cell by virtue of a specific secretion system of the attenuated salmonella after administration in an oral way. The delivered antigenic protein can be effectively treated and presented by antigen presenting cells, and finally, the immune system is activated/regulated, an antibody is generated, and the effect of a vaccine is achieved.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Owner NANJING JIRUIKANG BIOTECHNOLOGY RES INST CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com